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Summary
Primary hypothyroidism is a common endocrine condition, most commonly caused by autoimmune thyroiditis 
(Hashimoto’s disease) while Graves’ disease is the most common cause of hyperthyroidism. Hypothyroidism is usually 
a permanent condition in most patients requiring lifelong levothyroxine treatment. Transformation from Hashimoto’s 
disease to Graves’ disease is considered rare but recently been increasingly recognised. We describe a case of a 61-year-
old lady who was diagnosed with hypothyroidism approximately three decades ago and treated with levothyroxine 
replacement therapy. Approximately 27 years after the initial diagnosis of hypothyroidism, she started to become 
biochemically and clinically hyperthyroid. This was initially managed with gradual reduction in the dose of levothyroxine, 
followed by complete cessation of the medication, but she remained hyperthyroid, ultimately requiring anti-thyroid 
treatment with Carbimazole. This case highlights that there should be a high index of suspicion for a possible conversion 
of hypothyroidism to hyperthyroidism, even many years after the initial diagnosis of hypothyroidism. To our knowledge, 
this case illustrates the longest reported time interval between the diagnosis of hypothyroidism until the conversion to 
hyperthyroidism.
Background
Hashimoto’s thyroiditis and Graves’ disease are the 
most common autoimmune thyroid conditions 
and are more common in women than in men (1). 
Both conditions are characterised by symptoms and 
signs on the opposite spectrum of the scale and have 
entirely different appearances on radioactive iodine 
nuclear imaging studies. Although cases of conversion 
from hyperthyroidism to hypothyroidism are often 
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Learning points:
 • Occurrence of Graves’ disease after primary hypothyroidism is uncommon but possible.
 • In this case, there was a time-lapse of almost 28 years and therefore this entity may not be as rare as previously 
thought.
 • Diagnosis requires careful clinical and biochemical assessment. Otherwise, the case can be easily confused for over-
replacement of levothyroxine.
 • We suggest measuring both anti-thyroid peroxidase (TPO) antibodies and TSH receptor antibodies (TRAB) in 
suspected cases.
 • The underlying aetiology for the conversion is not exactly known but probably involves autoimmune switch by an 
external stimulus in genetically susceptible individuals.
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encountered in clinical practice, it is rare to see conversion 
of primary hypothyroidism due to Hashimoto’s disease 
to hyperthyroidism due to Graves’ disease (2, 3). The 
exact incidence of this conversion is not known due to 
its presumed rarity, and we could only find a limited 
number of similar cases in the literature, where this 
process took place over a variable time course spanning 
from months to years. Despite its rarity, it is possible that 
patients developing this conversion could be encountered 
by primary care physicians as well as hospital-based 
doctors and may be mistaken for over-replacement 
of levothyroxine. Treatment is straightforward with 
anti-thyroid medications once the diagnosis is confirmed.
Case presentation
We describe the case of a 61-year-old lady diagnosed with 
primary hypothyroidism back in 1988, based on tiredness, 
fatigue and a high thyroid-stimulating hormone (TSH) 
of 7.1 mU/L (normal: 0.27–4.2 mU/L). No concomitant 
free T4 or antibodies were checked, and an ultrasound 
scan was not done at that time. She was managed with 
levothyroxine replacement therapy 100 µg (1.3 µg/kg/day) 
since the diagnosis was made. Her comorbidities are type 
2 diabetes, hypertension, dyslipidaemia and gout. Her 
other regular medications include insulin, irbesartan, 
hydrochlorothiazide, bisoprolol, simvastatin and 
allopurinol. She works as a social worker in a residential 
home. She is an ex-smoker, having quit smoking at 
the age of 24 years and drinks alcohol rarely (less than 
14 units/week).
In 2015, and after having been on her usual 
levothyroxine 100 µg daily since the initial diagnosis 
of hypothyroidism in 1988, her general practitioner 
(GP) noticed a hyperthyroid picture on routine blood 
test for the first time after 27  years. That biochemical 
derangement was attributed to possible over-replacement 
of levothyroxine. It was decided to gradually reduce the 
levothyroxine dose, while having periodic monitoring 
of the thyroid function. At the start of January 2017, 
it was found that her TSH was completely suppressed 
(Fig. 1) and that the free T4 rose up to 71 pmol/L (normal 
12–22 pmol/L) despite reduction in levothyroxine 
dose (Fig.  2). The GP completely stopped her thyroid 
hormone replacement and referred her for specialist’s 
opinion.
This lady was subsequently reviewed in the 
outpatient endocrinology clinic. On further enquiring, 
she reported symptoms of excessive tiredness and 
sweating for last 24 months. She also noticed weight loss 
of approximately 10 kg during the same time. There was 
no history of palpitations or diarrhoea. Family history was 
significant for thyroid disease in her father and paternal 
grandmother. Although she was not aware of the exact 
details of the nature of the thyroid disease, she reported 
that her father had an underactive thyroid, which 
eventually became overactive after unspecified time. On 
examination, she had fine tremors of her outstretched 
hands, and there was bilateral exophthalmos with lid lag 
present. Although she was not complaining of any eye 
symptoms, exophthalmos was noticed both by primary 
care physician and the endocrinology consultant. She 
had a Clinical Activity Score of 2 (mild redness of the 
conjunctiva and swelling of eyelids). Lid retraction was 
less than 2 mm. There was no documentation of the 
degree of exophthalmos. There was diffuse thyromegaly 
with right lobe more prominent than the left lobe and 
an audible thyroid bruit. Unfortunately, there was 
no documented record of the thyroid volume in her 
retrospectively reviewed clinical notes. It was noticed in 
Figure 1
TSH levels over time.
Figure 2
T4 levels over time. She was on a stable dose of levothyroxine of 100 µg 
since diagnosis, until 2016. In 2016, the GP gradually reduced the dose to 
75 µg daily, and then 75 and 50 µg on alternate days. As she remained 
hyperthyroid, in January 2017, the GP completely stopped the 
levothyroxine, as the TSH was suppressed and the T4 was 71.5 pmol/L.
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her previous blood results from 2006 onwards that her 
TSH levels had always been within the normal range on 
a stable dose of levothyroxine 100 µg daily until 2015, 
where they became persistently low (Fig. 1).
Before the onset of the hyperthyroidism symptoms, 
she had an upper respiratory tract infection, for which 
she empirically received antibiotics in the community by 
her GP. No specific investigations like blood or sputum 
cultures or X-rays were done. However, according to the 
patient, following this infection, her diabetes became 
uncontrolled requiring her to go on insulin, her white 
cell count dropped and then a few weeks later, her 
thyroid function tests (TFTs) started to become deranged. 
Beginning from that episode of illness in January 
2015, her thyroid biochemistry became inconsistent, 
gradually shifting to a hyperthyroid picture. A TSH 
check in August 2014 was 0.5 mU/L. In January 2015, 
it was <0.02 mU/L and on a repeat TFTs in June 2015 
the TSH was <0.02 mU/L and free T4 was 89.2 pmol/L. 
This is when she also started developing hyperthyroid 
symptoms. It is difficult to ascertain what exactly caused 
this conversion, which happened to coincide with the 
upper respiratory tract infection, and it is difficult to 
prove a causal association between those two. However, it 
is plausible that the infection, probably a viral one, could 
have switched the conversion from the TSH-blocking 
antibodies to TSH-stimulating antibodies, making her 
clinically and biochemically hyperthyroid. Interestingly, 
her father had underactive thyroid which eventually 
became overactive. This points to the fact that there may 
be genetic susceptibility in addition to an environmental 
trigger causing the conversion from hypothyroidism to 
hyperthyroidism. Further research is, however, warranted 
to prove this.
Investigation
Her blood results have been consistent with 
hypothyroidism until 2015, when she developed a 
hyperthyroid picture (Figs 1 and 2). The anti-TPO levels 
came back as equivocal at 83 IU/mL (negative <60, 
equivocal: 60–100 IU/mL) and the TRAB was elevated 
at 15.8 IU/L (<0.9 IU/L), confirming the autoimmune 
basis of the underlying problem. No thyroid-stimulating 
antibody or thyroid-blocking antibody was checked. 
Only diagnostic, and not serial, TRAB was performed as 
per local policy. A thyroid uptake scan was suggestive of 
early Graves’ disease (Fig. 3). A full autoimmune screen 
was not performed but coeliac screen was negative.
Treatment
Based on the above results, there was little doubt that 
patient had underlying Graves’ disease now and was 
commenced on Carbimazole 30 mg once a day in 2017.
Outcome and follow-up
She was followed up in the endocrine clinic reporting 
improvement in her symptoms and a weight gain of 6 kg 
following the initiation of anti-thyroid treatment, over 
a period of 4  months. She is now clinically euthyroid. 
Because of the biochemical and clinical improvement, 
the dose of Carbimazole was reduced from 30 mg to 20 mg 
daily. Her latest TFTs on Carbimazole 20 mg daily showed 
that her TSH has remained suppressed with a free T4 of 
15.7 pmol/L (Fig. 2 and Table 1).
Discussion
In this case report, we describe a middle-aged lady who was 
initially diagnosed with hypothyroidism approximately 
30  years ago. She remained euthyroid on stable doses 
of levothyroxine before converting to hyperthyroidism 
Figure 3
Results of thyroid nuclear scan using Technetium 99m. Diffuse 
homogeneous uptake throughout both lobes of the thyroid with no 
evidence of toxic nodule or thyroiditis. These appearances could be 
suggestive of early Graves’ disease.
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secondary to Graves’ disease with strongly positive TRAB. 
Primary hypothyroidism once diagnosed usually requires 
lifelong thyroid hormone replacement. Although similar 
cases have been described in literature, none has been 
reported after such a long period of almost 30 years.
The first similar case was described by Joplin and 
Fraser in 1959 (4) and was followed by several others 
in the later 60s and 70s (5, 6, 7). In 1990 Takasu et  al. 
(3) described a case series of eight cases converting to 
Graves’ disease following Hashimoto’s disease, and 
it was observed that those cases could be divided into 
three groups: a group of transient Graves’ disease 
following hypothyroidism, a group of persistent Graves’ 
thyrotoxicosis following hypothyroidism and a group 
of persistent hypothyroidism despite positive thyroid-
stimulating immunoglobulins.
What causes this conversion is not well understood, 
but there are different theories postulated. In this case, 
it happened after an upper respiratory tract infection, 
and this could implicate an environmental trigger 
in a genetically susceptible individual as a possible 
mechanism. One early study (6), as well as Takasu et al. 
(3) believe that the alterations in thyroid state were 
related to the balance in the activity of stimulating 
and blocking antibodies and the response of thyroid 
gland to these antibodies. More recently, Moriarty 
et al. (8) described a case of conversion of autoimmune 
hypothyroidism to hyperthyroidism with thyroid 
eye disease. They believe that a variable behaviour of 
the TRAB with the TSH receptor is responsible for the 
conversion from hypothyroidism to hyperthyroidism 
and vice versa. Furgan et  al. (2) who also described 
three cases of autoimmune hypothyroidism converting 
to hyperthyroidism, proposed two theories to explain 
this conversion: first is the presence of both blocking 
and stimulating antibodies causing a pull–push effect 
shifting either to hypothyroidism or hyperthyroidism 
respectively, and a second theory is that thyroid damage 
from an autoimmune phenomenon initially causes 
thyroid hypofunction but once enough tissue has 
recovered, it is stimulated by stimulating antibodies. 
They also suggested that this conversion from 
hypothyroidism to hyperthyroidism may not be as rare 
as previously thought. One of the largest recent studies 
was done by Takasu and Matsushita (9). They identified 
34 patients with hypothyroidism with TSH receptor-
blocking antibodies and 98 patients with Graves’ disease 
with TSH receptor-stimulating antibodies and followed 
the natural course over 10  years. They concluded 
that hypothyroidism due to blocking antibodies and 
hyperthyroidism with stimulating antibodies may be 
two aspects of the same condition or disease.
We believe that genetically susceptible individuals may 
require an external trigger to switch from autoimmune 
hypothyroidism to Graves’ disease, such as an infection 
or neck irradiation (10), which would cause the balance 
to shift from TSH receptor-blocking antibodies to TSH 
receptor-stimulating antibodies. This phenomenon may 
not be as rare as previously thought and the physicians 
should be aware of this possibility if someone with a 
previously well-established hypothyroidism is now 
requiring less or no thyroid hormone replacement, and 
the TFTs keep demonstrating an overactive picture with 
no obvious reason, even many years after the diagnosis 
of hypothyroidism as in this case. Further research, 
however, is needed to establish the exact pathogenesis of 
this phenomenon.
Patient’s perspective
Patient’s perspective available on demand.
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Table 1 TFTs since starting Carbimazole.
Apr 2017 Jun 2017 Aug 2017 Sep 2017 Nov 2017 Feb 2018
TSH (mU/L) <0.02 <0.02 <0.02 <0.02 <0.02 <0.02
fT4 (pmol/L) 49.7 29.3 19.4 18.8 18.4 15.7
TFTs since starting Carbimazole treatment.
fT4, free T4.
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